Related Experiment Video
Updated: Aug 6, 2026

Short Session High Intensity Interval Training and Treadmill Assessment in Aged Mice
Published on: February 2, 2019
Effects of high-intensity interval training and moderate-intensity continuous training on type 2 diabetes mellitus: a
Fan Zeng1, Mengke Zhu1, Yang Yang1
1School of Leisure Sports and Tourism, Beijing Sport University, Beijing, China.
Abstract:
This meta-analysis compared the effects of high-intensity interval training (HIIT) and moderate-intensity continuous training (MICT) on type 2 diabetes (T2DM). A systematic search of the PubMed, Web of Science, Cochrane Library and Embase databases (from the inception of each database to 16 November 2025) identified a total of 21 randomized controlled trials involving 792 participants. A pooled analysis was conducted using standardized mean differences (SMD) and 95% confidence intervals. The results showed no significant differences between HIIT and MICT in terms of glycated hemoglobin (HbA1c), fasting blood glucose, HOMA-IR, body mass index (BMI), total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL) or blood pressure. However, HIIT demonstrated a significant advantage in improving high-density lipoprotein cholesterol (HDL) (SMD 0.44, p = 0.023). Subgroup analyses indicated that moderate training duration (20-30 minutes), lower weekly training frequency (≤3 sessions) and shorter intervention duration (≤8 weeks) optimized the benefits of HIIT on HDL. These findings suggest that HIIT is an effective alternative to MICT for patients with type 2 diabetes, particularly those with time constraints and whose primary metabolic abnormality is characterized by low HDL levels. Personalized exercise prescriptions should consider training duration and weekly training frequency as key modifiers.
Systematic Review Registration:
https://www.crd.york.ac.uk/PROSPERO/, identifier CRD420261343976.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type II Diabetes II: Pathophysiology
Type II Diabetes I: Introduction
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...